These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11673057)

  • 1. Catabolism of the coagulation factor VIII: can we prolong lifetime of f VIII in circulation?
    Ananyeva NM; Kouiavskaia DV; Shima M; Saenko EL
    Trends Cardiovasc Med; 2001 Aug; 11(6):251-7. PubMed ID: 11673057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein.
    Sarafanov AG; Ananyeva NM; Shima M; Saenko EL
    J Biol Chem; 2001 Apr; 276(15):11970-9. PubMed ID: 11278379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the low-density lipoprotein receptor-related protein regions involved in binding to the A2 domain of coagulation factor VIII.
    Sarafanov AG; Makogonenko EM; Andersen OM; Mikhailenko IA; Ananyeva NM; Khrenov AV; Shima M; Strickland DK; Saenko EL
    Thromb Haemost; 2007 Dec; 98(6):1170-81. PubMed ID: 18064310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism.
    Saenko EL; Yakhyaev AV; Mikhailenko I; Strickland DK; Sarafanov AG
    J Biol Chem; 1999 Dec; 274(53):37685-92. PubMed ID: 10608826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of coagulation factor VIII A2 domain residues forming the binding epitope for low-density lipoprotein receptor-related protein.
    Sarafanov AG; Makogonenko EM; Pechik IV; Radtke KP; Khrenov AV; Ananyeva NM; Strickland DK; Saenko EL
    Biochemistry; 2006 Feb; 45(6):1829-40. PubMed ID: 16460029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.
    Hartholt RB; van Velzen AS; Peyron I; Ten Brinke A; Fijnvandraat K; Voorberg J
    Blood Rev; 2017 Sep; 31(5):339-347. PubMed ID: 28716211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein.
    Lenting PJ; Neels JG; van den Berg BM; Clijsters PP; Meijerman DW; Pannekoek H; van Mourik JA; Mertens K; van Zonneveld AJ
    J Biol Chem; 1999 Aug; 274(34):23734-9. PubMed ID: 10446132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The physiology and pathophysiology of the factor VIII complex.
    Hamer RJ; Houdijk WP; Sixma JJ
    Crit Rev Oncol Hematol; 1986; 6(1):19-54. PubMed ID: 3096583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of haemophilia A.
    Oldenburg J; Ananyeva NM; Saenko EL
    Haemophilia; 2004 Oct; 10 Suppl 4():133-9. PubMed ID: 15479386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
    Yada K; Nogami K; Shima M
    Br J Haematol; 2013 Oct; 163(1):104-11. PubMed ID: 23889549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of coagulation factor VIII in very low-density lipoprotein receptor knockout mice.
    Bovenschen N; van Dijk KW; Havekes LM; Mertens K; van Vlijmen BJ
    Br J Haematol; 2004 Sep; 126(5):722-5. PubMed ID: 15327526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice.
    Schwarz HP; Lenting PJ; Binder B; Mihaly J; Denis C; Dorner F; Turecek PL
    Blood; 2000 Mar; 95(5):1703-8. PubMed ID: 10688827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency.
    Bovenschen N; Herz J; Grimbergen JM; Lenting PJ; Havekes LM; Mertens K; van Vlijmen BJ
    Blood; 2003 May; 101(10):3933-9. PubMed ID: 12522008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of coagulation factor VIII with members of the low-density lipoprotein receptor family follows common mechanism and involves consensus residues within the A2 binding site 484-509.
    Ananyeva NM; Makogonenko YM; Sarafanov AG; Pechik IV; Gorlatova N; Radtke KP; Shima M; Saenko EL
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):543-55. PubMed ID: 18685438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol containing lipidic particles reduces immunogenicity and catabolism of factor VIII in hemophilia a mice.
    Peng A; Straubinger RM; Balu-Iyer SV
    AAPS J; 2010 Sep; 12(3):473-81. PubMed ID: 20517659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between factor VIII and LDL receptor-related protein. Modulation of coagulation?
    Neels JG; Bovenschen N; van Zonneveld AJ; Lenting PJ
    Trends Cardiovasc Med; 2000 Jan; 10(1):8-14. PubMed ID: 11150722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic cleavage of factor VIII heavy chain is required to expose the binding-site for low-density lipoprotein receptor-related protein within the A2 domain.
    Bovenschen N; van Stempvoort G; Voorberg J; Mertens K; Meijer AB
    J Thromb Haemost; 2006 Jul; 4(7):1487-93. PubMed ID: 16839343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.
    Gangadharan B; Ing M; Delignat S; Peyron I; Teyssandier M; Kaveri SV; Lacroix-Desmazes S
    Haematologica; 2017 Feb; 102(2):271-281. PubMed ID: 27758819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.